Thoma Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Sell
1,014
-28
-3% -$33K 0.61% 17
2026
Q2
$1.25M Sell
1,042
-28
-3% -$28.6K 0.67% 16
2026
Q1
$985K Buy
1,070
+67
+7% +$67.9K 0.58% 24
2025
Q4
$1.08M Sell
1,003
-64
-6% -$61.2K 0.62% 19
2025
Q3
$814K Buy
1,067
+2
+0.2% +$1.49K 0.47% 31
2025
Q2
$830K Buy
1,065
+5
+0.5% +$3.88K 0.53% 25
2025
Q1
$876K Hold
1,060
– – 0.61% 20
2024
Q4
$819K Buy
+1,060
New +$878K 0.56% 25

Other funds holding LLY

Thoma Capital Management's LLY Position: Q3 2026 in Review

Thoma Capital Management reduced its Eli Lilly (LLY) stake by 2.7% in Q3 2026, selling an estimated $33K and leaving 1,014 shares worth $1.17M. The position accounts for 0.61% of the portfolio, ranked #17.

Thoma Capital Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Thoma Capital Management held 1,014 shares of Eli Lilly worth $1.17M as of Q3 2026.
  • Thoma Capital Management sold 28 Eli Lilly shares in Q3 2026, an estimated $33K.
  • Eli Lilly made up 0.61% of Thoma Capital Management's portfolio in Q3 2026, its #17 holding.
  • Thoma Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Thoma Capital Management's Eli Lilly position peaked at $1.25M in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Thoma Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.